The clinical professor of neurology and pediatrics at The Ohio State University Wexner Medical Center discussed payer step therapy, earlier preventive treatment, and questions the updated guideline leaves open.
|Slideshows|February 19, 2018
Increased Intracranial Pressure and Fluoroquinolones
Author(s)Veronica Hackethal, MD
A study suggests an increase in the risk for pseudotumor cerebri syndrome with current users of fluoroquinolones. When is medical attention warranted?
Advertisement
Advertisement
Related to this article
Here's some of what is coming soon to NeurologyLive® this week.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Examining Trontinemab in Early Alzheimer Disease: The Phase 3 TRONTIER 1 and 2 Trials
2
How MS Understanding Has Evolved: Activity, Impact, and Progression
3
Benitec Reports Positive Interim Results for BB-301 in Oculopharyngeal Muscular Dsytrophy
4
Remibrutinib Phase 3 Results in RMS, Blood Pressure Variability Findings, and Updated Stroke Rehabilitation Guidelines
5